AN 2728 in paediatric and adolescent patients with atopic dermatitis: MUSE trial.
Phase of Trial: Phase I
Latest Information Update: 01 Jul 2016
At a glance
- Drugs Crisaborole (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Pharmacokinetics
- Acronyms MUSE
- 19 Oct 2015 According to Leo Pharma media release, the US FDA has approved Enstilar for the treatment of plaque psoriasis.
- 13 Nov 2013 New trial record
- 12 Nov 2013 Interim results reported in an Anacor Pharmaceuticals media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History